Log in

NASDAQ:OCULOcular Therapeutix News Headlines

$4.78
+0.02 (+0.42 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.54
Now: $4.78
$4.81
50-Day Range
$4.06
MA: $5.20
$7.40
52-Week Range
$2.35
Now: $4.78
$8.12
Volume368,167 shs
Average Volume1.24 million shs
Market Capitalization$251.33 million
P/E RatioN/A
Dividend YieldN/A
Beta1.62

Headlines

Ocular Therapeutix (NASDAQ OCUL) News Headlines

Source:
DateHeadline
Ocular Therapeutix Inc (NASDAQ:OCUL) Expected to Announce Quarterly Sales of $3.09 MillionOcular Therapeutix Inc (NASDAQ:OCUL) Expected to Announce Quarterly Sales of $3.09 Million
www.americanbankingnews.com - April 4 at 2:26 AM
 Analysts Anticipate Ocular Therapeutix Inc (NASDAQ:OCUL) to Post -$0.37 Earnings Per Share Analysts Anticipate Ocular Therapeutix Inc (NASDAQ:OCUL) to Post -$0.37 Earnings Per Share
www.americanbankingnews.com - April 2 at 7:52 PM
Summer Road Llc Purchases 109,100 Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) StockSummer Road Llc Purchases 109,100 Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) Stock
www.americanbankingnews.com - March 25 at 4:16 AM
Summer Road Llc Acquires 40,900 Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) StockSummer Road Llc Acquires 40,900 Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) Stock
www.americanbankingnews.com - March 23 at 12:52 PM
Ocular Therapeutix Inc to Post Q1 2020 Earnings of ($0.29) Per Share, Jefferies Financial Group Forecasts (NASDAQ:OCUL)Ocular Therapeutix Inc to Post Q1 2020 Earnings of ($0.29) Per Share, Jefferies Financial Group Forecasts (NASDAQ:OCUL)
www.americanbankingnews.com - March 20 at 8:01 AM
Summer Road Llc Purchases 210,800 Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) StockSummer Road Llc Purchases 210,800 Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) Stock
www.americanbankingnews.com - March 18 at 4:48 AM
Insider Buying: Ocular Therapeutix Inc (NASDAQ:OCUL) Major Shareholder Buys 955,062 Shares of StockInsider Buying: Ocular Therapeutix Inc (NASDAQ:OCUL) Major Shareholder Buys 955,062 Shares of Stock
www.americanbankingnews.com - March 18 at 4:16 AM
Jefferies Financial Group Begins Coverage on Ocular Therapeutix (NASDAQ:OCUL)Jefferies Financial Group Begins Coverage on Ocular Therapeutix (NASDAQ:OCUL)
www.americanbankingnews.com - March 17 at 4:23 PM
Ocular Therapeutix Inc (NASDAQ:OCUL) Receives Average Recommendation of "Buy" from AnalystsOcular Therapeutix Inc (NASDAQ:OCUL) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 15 at 1:36 AM
Ocular Therapeutix (NASDAQ:OCUL) Issues Quarterly  Earnings Results, Misses Estimates By $0.08 EPSOcular Therapeutix (NASDAQ:OCUL) Issues Quarterly Earnings Results, Misses Estimates By $0.08 EPS
www.americanbankingnews.com - March 13 at 10:30 PM
Edited Transcript of OCUL earnings conference call or presentation 12-Mar-20 8:30pm GMTEdited Transcript of OCUL earnings conference call or presentation 12-Mar-20 8:30pm GMT
finance.yahoo.com - March 13 at 5:24 PM
Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q4 2019 Results - Earnings Call TranscriptOcular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 13 at 1:21 AM
Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue EstimatesOcular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 13 at 1:21 AM
Ocular Therapeutix EPS misses by $0.08, misses on revenueOcular Therapeutix EPS misses by $0.08, misses on revenue
seekingalpha.com - March 12 at 8:21 PM
Ocular Therapeutix: 4Q Earnings SnapshotOcular Therapeutix: 4Q Earnings Snapshot
finance.yahoo.com - March 12 at 8:21 PM
BRIEF-Ocular Therapeutix™ Reports Fourth Quarter And Year End 2019 Financial Results And Business UpdateBRIEF-Ocular Therapeutix™ Reports Fourth Quarter And Year End 2019 Financial Results And Business Update
www.reuters.com - March 12 at 8:21 PM
Ocular Therapeutix™ Reports Fourth Quarter and Year End 2019 Financial Results and Business UpdateOcular Therapeutix™ Reports Fourth Quarter and Year End 2019 Financial Results and Business Update
finance.yahoo.com - March 12 at 8:21 PM
Ocular Therapeutix, Inc. to Host Earnings CallOcular Therapeutix, Inc. to Host Earnings Call
finance.yahoo.com - March 12 at 3:20 PM
$2.30 Million in Sales Expected for Ocular Therapeutix Inc (NASDAQ:OCUL) This Quarter$2.30 Million in Sales Expected for Ocular Therapeutix Inc (NASDAQ:OCUL) This Quarter
www.americanbankingnews.com - March 12 at 6:36 AM
Ocular Therapeutix Inc (NASDAQ:OCUL) Expected to Announce Earnings of -$0.43 Per ShareOcular Therapeutix Inc (NASDAQ:OCUL) Expected to Announce Earnings of -$0.43 Per Share
www.americanbankingnews.com - March 10 at 2:14 AM
Ocular Therapeutix™ To Report Fourth Quarter and Year-End 2019 Financial ResultsOcular Therapeutix™ To Report Fourth Quarter and Year-End 2019 Financial Results
finance.yahoo.com - March 5 at 9:55 AM
Ocular Therapeutix +9% as Piper hikes targetOcular Therapeutix +9% as Piper hikes target
seekingalpha.com - March 4 at 7:14 PM
Ocular Therapeutix up 31% on Dextenza ramp, encouraging data on eye implantOcular Therapeutix up 31% on Dextenza ramp, encouraging data on eye implant
seekingalpha.com - March 4 at 2:13 PM
Heres Why Shares of Ocular Therapeutix Rocketed Higher TodayHere's Why Shares of Ocular Therapeutix Rocketed Higher Today
www.fool.com - March 4 at 2:13 PM
Ocular Therapeutix™ Announces Preliminary Fourth Quarter 2019 Net Product Revenue and Provides Update on Interim Data from the OTX-TKI Phase 1 Clinical Trial at the Cowen 40th Annual Health Care ConferenceOcular Therapeutix™ Announces Preliminary Fourth Quarter 2019 Net Product Revenue and Provides Update on Interim Data from the OTX-TKI Phase 1 Clinical Trial at the Cowen 40th Annual Health Care Conference
finance.yahoo.com - March 3 at 8:24 AM
Medical Grade Hydrogel Market 2020 | Potential Growth, Current Scenario, Size, Share, Prominent Players, Demand and TrendsMedical Grade Hydrogel Market 2020 | Potential Growth, Current Scenario, Size, Share, Prominent Players, Demand and Trends
www.marketwatch.com - March 2 at 9:05 AM
Ocular Therapeutix™ to Present at the Cowen and Company 40th Annual Health Care ConferenceOcular Therapeutix™ to Present at the Cowen and Company 40th Annual Health Care Conference
finance.yahoo.com - February 25 at 12:20 PM
Loss-Making Ocular Therapeutix, Inc. (NASDAQ:OCUL) Expected To BreakevenLoss-Making Ocular Therapeutix, Inc. (NASDAQ:OCUL) Expected To Breakeven
finance.yahoo.com - February 18 at 9:05 AM
Ocular Therapeutix (NASDAQ: OCUL)Ocular Therapeutix (NASDAQ: OCUL)
www.benzinga.com - February 10 at 6:35 PM
BRIEF-Ocular Therapeutix Therapy Demonstrates Clinically-Meaningful Reduction in Intraocular PressureBRIEF-Ocular Therapeutix Therapy Demonstrates Clinically-Meaningful Reduction in Intraocular Pressure
www.reuters.com - February 7 at 2:27 PM
Ocular Therapeutix up 11% premarket on encouraging OTX-TIC dataOcular Therapeutix up 11% premarket on encouraging OTX-TIC data
seekingalpha.com - February 7 at 9:26 AM
Ocular Therapeutix™ Presents Data Demonstrating a Clinically-Meaningful Reduction in Intraocular Pressure in Patients with Primary Open Angle Glaucoma or Ocular Hypertension Treated with OTX-TIC at Glaucoma 360 ConferenceOcular Therapeutix™ Presents Data Demonstrating a Clinically-Meaningful Reduction in Intraocular Pressure in Patients with Primary Open Angle Glaucoma or Ocular Hypertension Treated with OTX-TIC at Glaucoma 360 Conference
finance.yahoo.com - February 7 at 9:26 AM
1st Circuit to weigh shareholders’ claims against Ocular Therapeutix1st Circuit to weigh shareholders’ claims against Ocular Therapeutix
www.reuters.com - February 5 at 12:04 AM
Ocular Therapeutix: Multiple Upside Drivers For This Platform Technology PlayOcular Therapeutix: Multiple Upside Drivers For This Platform Technology Play
seekingalpha.com - January 21 at 3:37 PM
Is Ocular Therapeutix, Inc. (NASDAQ:OCUL) Overpaying Its CEO?Is Ocular Therapeutix, Inc. (NASDAQ:OCUL) Overpaying Its CEO?
finance.yahoo.com - January 13 at 4:53 PM
At 4.9% CAGR, Hydrogel Market Size is Expected to Exhibit 1738.3 million USD by 2026At 4.9% CAGR, Hydrogel Market Size is Expected to Exhibit 1738.3 million USD by 2026
www.marketwatch.com - January 9 at 8:11 AM
Ocular Therapeutix: Executing On Dextenzas Launch, A Name To Own In 2020Ocular Therapeutix: Executing On Dextenza's Launch, A Name To Own In 2020
seekingalpha.com - December 30 at 9:30 AM
Ocular Drug Delivery Technology Market Research Report 2020 - Industry Statistical Study Of The Forecast Years 2020-2029Ocular Drug Delivery Technology Market Research Report 2020 - Industry Statistical Study Of The Forecast Years 2020-2029
www.marketwatch.com - December 26 at 8:13 AM
Did Hedge Funds Drop The Ball On Ocular Therapeutix Inc (OCUL) ?Did Hedge Funds Drop The Ball On Ocular Therapeutix Inc (OCUL) ?
finance.yahoo.com - December 23 at 8:46 PM
Ocular Drug Delivery Technology Market Latest Advancement And New Upcoming Trends To 2029Ocular Drug Delivery Technology Market Latest Advancement And New Upcoming Trends To 2029
www.marketwatch.com - December 17 at 8:19 AM
Retinal Drugs And Biologics Market Future Growth Analysis, Business Demand and Opportunities to 2027Retinal Drugs And Biologics Market Future Growth Analysis, Business Demand and Opportunities to 2027
www.marketwatch.com - December 9 at 8:04 AM
Ocular Therapeutix™ to Present at the Piper Jaffray 31st Annual Healthcare ConferenceOcular Therapeutix™ to Present at the Piper Jaffray 31st Annual Healthcare Conference
finance.yahoo.com - November 26 at 4:15 PM
Ocular Therapeutix (OCUL) Presents At Jefferies Global Healthcare Conference - SlideshowOcular Therapeutix (OCUL) Presents At Jefferies Global Healthcare Conference - Slideshow
seekingalpha.com - November 22 at 2:45 PM
Ocular Therapeutix™ to Present at the Jefferies 2019 London Healthcare ConferenceOcular Therapeutix™ to Present at the Jefferies 2019 London Healthcare Conference
finance.yahoo.com - November 14 at 8:33 AM
Edited Transcript of OCUL earnings conference call or presentation 12-Nov-19 1:00pm GMTEdited Transcript of OCUL earnings conference call or presentation 12-Nov-19 1:00pm GMT
finance.yahoo.com - November 13 at 12:44 AM
Ocular Therapeutix down 7% on Q3 resultsOcular Therapeutix down 7% on Q3 results
seekingalpha.com - November 12 at 2:43 PM
Ocular Therapeutix, Inc.s (OCUL) CEO Antony Mattessich on Q3 2019 Results - Earnings Call TranscriptOcular Therapeutix, Inc.'s (OCUL) CEO Antony Mattessich on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 2:43 PM
Ocular Therapeutix™ Reports Third Quarter 2019 Financial Results and Business UpdateOcular Therapeutix™ Reports Third Quarter 2019 Financial Results and Business Update
finance.yahoo.com - November 12 at 9:42 AM
Ocular Therapeutix (OCUL) Reports Q3 Loss, Misses Revenue EstimatesOcular Therapeutix (OCUL) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 12 at 9:42 AM
BRIEF-Ocular Therapeutix Announces Strategic Update And Operational RestructuringBRIEF-Ocular Therapeutix Announces Strategic Update And Operational Restructuring
www.msn.com - November 8 at 11:47 PM
This page was last updated on 4/4/2020 by MarketBeat.com Staff

Featured Article: Equal Weight Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel